课题基金 / 基金详情

Admin Core

Admin Core
管理核心
批准号:
10592381
负责人:
David R Andes
金额:
$31.48万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-01 至 2025-03-31
关键词:

项目摘要

项目成果

David R Andes的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Antimicrobial innovation has slowed to a crawl while an epidemic of antimicrobial-resistant infections surges, threatening the public health. The overarching goal of the Wisconsin Antimicrobial Drug Discovery and Development Center is to develop therapeutic countermeasures to tackle the antimicrobial resistance crisis. Based upon our preliminary data, we hypothesize that natural product exploration of symbiotic environments using complementary cutting-edge approaches will provide a new paradigm for discovery of novel antimicrobials targeting drug resistant infections. The Center proposes innovative conceptual and technical advances to overcome critical bottlenecks identified in traditional antimicrobial drug discovery platforms. The success of this endeavor hinges upon the cohesive efforts from a diverse group of scientists and technical resources. The Administrative Core will be directed by Andes and advised by an Internal and External Advisory Board comprised of experts in infectious diseases, antimicrobial resistance, drug discovery and development, natural products, and technology transfer and licensing. Additionally, it will include an administrator with extensive experience in research and business administration, and prior oversight of NIH funded program projects and centers. The overall goals of the administrative core are to provide leadership and the organizational back bone for this proposal, promote collaboration between the Projects and Cores, and coordinate its interaction with NIAID staff. /Relevance/ There are no effective therapies for the emerging resistant pathogens that are becoming an increasing threat to the public health. The goals of the Center are to provide new, broad spectrum antimicrobial agents through a collaborative focus on high value natural product leads produced by under-explored sources of biological diversity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi
  • 批准号:
    10584574
  • 项目类别:
  • 资助金额:
    $71.0万
  • 财政年份:
    2022
  • 负责人:
    David R Andes
  • 依托单位:
Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi
  • 批准号:
    10414553
  • 项目类别:
  • 资助金额:
    $77.75万
  • 财政年份:
    2022
  • 负责人:
    David R Andes
  • 依托单位:
Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course
  • 批准号:
    10461947
  • 项目类别:
  • 资助金额:
    $10.81万
  • 财政年份:
    2021
  • 负责人:
    David R Andes
  • 依托单位:
Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course
  • 批准号:
    10313447
  • 项目类别:
  • 资助金额:
    $10.81万
  • 财政年份:
    2021
  • 负责人:
    David R Andes
  • 依托单位:
国内基金
海外基金
胆固醇羟化酶CH25H非酶活依赖性促进乙型肝炎病毒蛋白Core及Pre-core降解的分子机制研究
  • 批准号:
    82371765
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    谭广云
  • 依托单位:
锕系元素5f-in-core的GTH赝势和基组的开发
  • 批准号:
    22303037
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    鲁俊波
  • 依托单位:
基于合成致死策略搭建Core-matched前药共组装体克服肿瘤耐药的机制研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    孙丙军
  • 依托单位:
鼠伤寒沙门氏菌LPS core经由CD209/SphK1促进树突状细胞迁移加重炎症性肠病的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    叶成林
  • 依托单位: